The relation between maternal anti-D concentrations, measured against the British working standard, and outcome of rhesus-sensitised pregnancies was studied.
Introduction
In spite of prophylaxis, rhesus haemolytic disease of the newborn remains an appreciable clinical problem.1 2 The management of affected pregnancies is helped by a prediction of outcome, which We examined the relation between maternal anti-D concentrations and outcome of rhesus-sensitised pregnancies in the Oxford region. This is the first such study to report anti-D concentrations measured, with the above modifications, directly against the British anti-D working standard. 6 In addition, a cell concen-tration of 5%, an interference filter of 410 nm, and a flow cell 8 mm long were substituted for those described by Marsh. The haemagglutinating activity of the test sera was compared with that of the British anti-D working standard (72/229). A second standard preparation was included in each test run to control the primary working standard. A variation of the secondary standard value from its established mean value of > 10% (2 standard deviations) required that the whole test run should be repeated.
Results
During the study there were 109 000 births in the Oxford region. Seven babies died from haemolytic disease of the newborn, (0 07/1000 births) and 380 women were found to have anti-D antibodies during pregnancy (3-5/1000 births). Of these 380 women, 260 were studied in detail. Five pregnancies were managed with intrauterine transfusion: two babies survived (initial anti-D concentrations of 7 9 IU/ml and 28 IU/ml) and three died (initial anti-D concentrations of 45 IU/ml, 104 IU/ml, and 104 IU/ml). Four Conversion: SI to traditional units-Bilirubin: 1 ,Lmol/l 0-06 mg/100 ml. BRITISH MEDICAL JOURNAL VOLUME 285 31 JULY 1982 260 IU/ml and 345 IU/ml). There was one intrauterine death with an initial anti-D at 16 weeks of 4 6 IU/ml, which at the time of death (28 weeks) had risen to 168 IU/ml. The remaining 250 pregnancies resulted in live births; amniocentesis was performed at the clinician's discretion. One baby died shortly after birth (gestation 28 weeks, cord haemoglobin concentration 2 7 g/dl, maximum maternal anti-D 28 IU/ml). The average number of anti-D estimations per pregnancy was six (range two to 16). These 250 pregnancies resulted in 184 rhesus-positive and 66 rhesus-negative babies. Table I concentrations showed little change in about one-third of the pregnancies producing rhesus-positive babies and two-thirds of those producing rhesus-negative babies. It was decided to use maximum anti-D concentrations, a clinically simple value, to predict the outcome of the pregnancy. We were unable to improve the predictive power of maximum anti-D concentrations by taking the rate of rise of anti-D concentrations or the gestation into consideration. For the purposes of subsequent analysis, therefore, the pregnancies resulting in rhesus-positive babies were divided into the following groups based on maximum anti-D concentrations: 52 with maximum concentrations of 0-2 IU/ml, 26 with concentrations of 2-4 IU/ml, 29 with 4-8 IU/ml, 24 with 8-16 IU/ml, 28 with 16-32 IU/ml, and 25 with over 32 IU/ml. and below 14 g/dl, cord bilirubin values above 80 ,mol/l (4 7 mg/100 ml), and the incidence of exchange transfusions. Figure 2 shows the probability of a severe outcome, by this definition, with maximum anti-D concentrations. The chance of a baby being severely affected is related to anti-D concentrations, with a considerably increased likelihood of such an outcome when the maximum anti-D concentration is above 4 IU/ml.
The cord haemoglobin and bilirubin concentrations and the treatment of babies was analysed with respect to the mothers' previous history of babies with haemolytic disease of the newborn (see table II for analysis of cord haemoglobin). After controlling for maximum anti-D concentrations, there was no difference in outcome for mothers either with or without a past history of haemolytic disease of the newborn. 13-0 ±0-88 (7) 14-4 ±1*35 (9) >16-32 12-5 ±1-02 (10) 11-6±0-82 (12) >32
11-I 1-14 (13) 11-2±1-13 (8) Discussion These results show the continuing morbidity and mortality of rhesus haemolytic disease of the newborn. To determine the value of anti-D measurements in the management of rhesussensitised pregnancies we analysed serial concentrations of anti-D against outcome of pregnancy.
The In sensitised pregnancies resulting in rhesus-negative babies, maternal anti-D concentrations would be expected to remain the same or to fall due to the increase in plasma volume and natural decline in antibody production. Those Of 78 such pregnancies resulting in rhesus-positive babies no baby had a cord haemoglobin below 10 g/dl; only three required exchange transfusion and in two of these there was good evidence of ABO haemolytic disease. We were not able to define a group of pregnancies associated with a high risk of fetal or neonatal death from our study as the total number of deaths was too small, though others have attempted such predictions. 8 11 This study shows the relation between maternal anti-D concentrations and outcome and should help in the management of rhesus-sensitised patients. We recommend that regular blood samples are taken fortnightly after the 20th week of gestation. This is of value in detecting sudden rises of anti-D and in deciding on the need for amniocentesis. Our results suggest that amniocentesis, known occasionally to cause secondary immunisation,12 13 could be avoided in low-risk patients.
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